{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:20:24Z","timestamp":1787556024513,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.phymed.2026.158639","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:12:57Z","timestamp":1784855577000},"page":"158639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emodinanthrone, a natural precursor of emodin, enhances T-cell anti-tumor via JAK3-STAT1\/3 signal and improves anti-PD-1 efficacy against colon cancer"],"prefix":"10.1016","volume":"160","author":[{"given":"Zhi","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Rao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158639_bib0001","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/molecules27020424","article-title":"Resveratrol and immune cells: a link to improve Human health","volume":"27","author":"Alesci","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2026.158639_bib0002","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41573-024-01051-x","article-title":"Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics","volume":"23","author":"Carter","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2026.158639_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154335","article-title":"Discovery of potent immune-modulating molecule taccaoside A against cancers from structures-active relationships of natural steroidal saponins","volume":"104","author":"Dai","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158639_bib0004","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ptr.5631","article-title":"Emodin: a review of its pharmacology, toxicity and pharmacokinetics","volume":"30","author":"Dong","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2026.158639_bib0005","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1158\/0008-5472.CAN-21-0952","article-title":"Improving tumor penetration of antibodies and antibody\u2013drug conjugates: taking away the barriers for trojan horses","volume":"81","author":"Dongen","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2026.158639_bib0006","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/biology12091163","article-title":"A story of kinases and adaptors: the role of Lck, ZAP-70 and LAT in switch panel governing T-cell development and activation","volume":"12","author":"Fern\u00e1ndez-Aguilar","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.phymed.2026.158639_bib0007","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41590-024-01804-1","article-title":"JAK-STAT signaling maintains homeostasis in T cells and macrophages","volume":"25","author":"Fortelny","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phymed.2026.158639_bib0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.12775\/JEHS.2024.60.015","article-title":"Turmeric: a spice modulating immune response and combatting cancer \u2013 literature overview","volume":"60","author":"Gregu\u0142a","year":"2024","journal-title":"J. Educ. Health Sport"},{"key":"10.1016\/j.phymed.2026.158639_bib0009","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1142\/S0192415X25500089","article-title":"Advances in pharmacological research on Icaritin: a comprehensive review","volume":"53","author":"Guo","year":"2025","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2026.158639_bib0010","doi-asserted-by":"crossref","first-page":"S1488","DOI":"10.1016\/j.annonc.2024.10.242","article-title":"222P The activity and safety of icaritin for patients with unresectable hepatocellular carcinoma: a real-world, retrospective study","volume":"35","author":"Hui","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2026.158639_bib0011","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/biomedicines12081917","article-title":"Icaritin exerts anti-cancer effects through modulating pyroptosis and immune activities in hepatocellular carcinoma","volume":"12","author":"Jiao","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.phymed.2026.158639_bib0012","article-title":"First-line treatment of Icaritin and Thalidomide in a patient with hepatocellular carcinoma with PR: a case report","volume":"8","author":"Jin","year":"2025","journal-title":"Cancer Rep."},{"key":"10.1016\/j.phymed.2026.158639_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/JLB.3CE0821-427RR","article-title":"Stabilizing the immune system by chlorogenic acid","volume":"112","author":"Kzhyshkowska","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phymed.2026.158639_bib0014","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41388-024-03271-2","article-title":"STK31 drives tumor immune evasion through STAT3-IL-6 mediated CD8+ T cell exhaustion","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2026.158639_bib0015","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.3390\/ijms25052977","article-title":"Janus Kinase 3 (JAK3): a critical conserved node in immunity disrupted in immune cell cancer and immunodeficiency","volume":"25","author":"Liongue","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158639_bib0016","first-page":"69","article-title":"Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma","volume":"9","author":"Lu","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.phymed.2026.158639_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70014","article-title":"The structural biology of T-cell antigen detection at close contacts","volume":"331","author":"Lui","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phymed.2026.158639_bib0018","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/ijms27031391","article-title":"Interleukins in COVID-19 and SARS-CoV-2 variants: immunopathogenesis, therapeutic perspectives and vaccine-induced immune responses","volume":"27","author":"Mahajan","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158639_bib0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/molecules31050833","article-title":"Emodin and the anthraquinone scaffold: therapeutic promise and strategies to overcome translational barriers","volume":"31","author":"Mihaylova","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2026.158639_bib0020","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158639_bib0021","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/j.apsb.2024.06.029","article-title":"Icaritin inhibits the progression of urothelial cancer by suppressing PADI2-mediated neutrophil infiltration and neutrophil extracellular trap formation","volume":"14","author":"Mou","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2026.158639_bib0022","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phymed.2026.158639_bib0023","doi-asserted-by":"crossref","DOI":"10.1186\/s13765-024-00881-y","article-title":"Ginsenosides as dietary supplements with immunomodulatory effects: a review","volume":"67","author":"Tang","year":"2024","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.phymed.2026.158639_bib0024","doi-asserted-by":"crossref","first-page":"eadp4670","DOI":"10.1126\/sciadv.adp4670","article-title":"Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma","volume":"10","author":"Tarantino","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phymed.2026.158639_bib0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12672-025-02240-9","article-title":"Role of emodin to prevent gastrointestinal cancers: recent trends and future prospective","volume":"16","author":"Thakral","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.phymed.2026.158639_bib0026","doi-asserted-by":"crossref","first-page":"25378","DOI":"10.1074\/jbc.M011363200","article-title":"Cytokine-independent Jak3 activation upon T cell receptor (TCR) stimulation through direct association of Jak3 and the TCR Complex*","volume":"276","author":"Tomita","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2026.158639_bib0027","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: new opportunities, better drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phymed.2026.158639_bib0028","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40164-024-00495-6","article-title":"Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies","volume":"13","author":"Wang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.phymed.2026.158639_bib0029","article-title":"Breaking the immune desert: strategies for overcoming the immunological challenges of pancreatic cancer","volume":"1880","author":"Wang","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158639_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217475","article-title":"FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity","volume":"612","author":"Wei","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158639_bib0031","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s10787-025-01795-x","article-title":"The therapeutic mechanisms of quercetin on inflammatory diseases: an update","volume":"33","author":"Xu","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phymed.2026.158639_bib0032","article-title":"Severe cytokine release syndrome induced by immune checkpoint inhibitors in cancer patients - A case report and review of the literature","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.phymed.2026.158639_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118262","article-title":"Comprehensive insights into emodin compounds research in medicinal chemistry","volume":"128","author":"Zhu","year":"2025","journal-title":"Bioorg. Med. Chem."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326008706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326008706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:32:17Z","timestamp":1787553137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326008706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S0944711326008706"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158639","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emodinanthrone, a natural precursor of emodin, enhances T-cell anti-tumor via JAK3-STAT1\/3 signal and improves anti-PD-1 efficacy against colon cancer","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158639"}}